IMMUNIC, INC. Files S-8 for Employee Stock Plans
Ticker: IMUX · Form: S-8 · Filed: Apr 9, 2026 · CIK: 0001280776
| Field | Detail |
|---|---|
| Company | Immunic, INC. (IMUX) |
| Form Type | S-8 |
| Filed Date | Apr 9, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: employee-benefit-plan, stock-registration, sec-filing
TL;DR
IMMUNIC just filed an S-8, meaning they're ready to give out stock to employees.
AI Summary
On April 9, 2026, IMMUNIC, INC. filed an S-8 form with the SEC, registering an unspecified number of securities to be offered under its employee benefit plans. This filing indicates the company is making shares available for its employees, likely as part of compensation or incentive programs. The filing does not specify a dollar amount for the offering.
Why It Matters
This filing allows IMMUNIC, INC. to issue stock to employees, which can be a key tool for attracting and retaining talent, and aligning employee interests with shareholder value.
Risk Assessment
Risk Level: low — An S-8 filing is a routine registration of securities for employee benefit plans and does not inherently represent a new financial risk or opportunity.
Key Players & Entities
- IMMUNIC, INC. (company) — Filer of the S-8 registration statement
- 0001280776 (company) — CIK number for IMMUNIC, INC.
- 2026-04-09 (date) — Filing date and effectiveness date of the S-8
FAQ
What type of securities are being registered?
The filing is an S-8, which registers securities to be offered to employees in connection with employee benefit plans. The specific type of security (e.g., common stock) is not detailed in the provided summary information.
How many shares are being registered?
The provided filing details do not specify the exact number of shares being registered under the S-8 form.
What is the purpose of this S-8 filing?
The purpose is to register securities for IMMUNIC, INC.'s employee benefit plans, allowing the company to issue these securities to employees.
When was this filing accepted by the SEC?
The filing was accepted on April 9, 2026.
What is IMMUNIC, INC.'s business?
IMMUNIC, INC. is in the Pharmaceutical Preparations industry, classified under SIC code 2834.
Filing Details
This Form S-8 (Form S-8) was filed with the SEC on April 9, 2026 regarding IMMUNIC, INC. (IMUX).